Prilocaine, Lidocaine - paediatric investigation plan

prilocaine

lidocaine

Key facts

• Active Substance:
  • prilocaine
  • lidocaine
• Therapeutic area:
  Uro-nephrology
• Decision number:
  P/79/2008
• PIP number:
  Prilocaine, Lidocaine
• Pharmaceutical form(s):
  • Cutaneous spray
  • Solution
• Condition(s) / indication(s):
  Premature ejaculation
• Route(s) of administration:
  Cutaneous use
• Contact for public enquiries:

  Plethora Solutions Limited

  E-mail: [e-mail]; Country: UK; Phone: [phone]; Fax: [phone]

• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  15/09/2008

Decision

P/79/2008: European medicines agency decision of 15 September 2007 on the application for product specific waiver for prilocaine, lidocaine (EMEA-000248-PIP01-08) in accordance with Regulation (EC) No 1901/2006 of the Eu...

AdoptedReference Number: EMEA/471376/2008